SCHEMBL20161408

SCHEMBL20161408

CC(C)C1CN(C)CCCN1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.34
ROCK1 Q13464 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL930081 0.87 PRKCQ (0.30)
SCHEMBL82212 0.87 PRKCQ (0.30)
SCHEMBL14110914 0.87 PRKCQ (0.30)
Hydrochloric Acid SCHEMBL27829628 0.85
SCHEMBL12356667 0.78 ROCK2 (0.33) ROCK2ROCK1
SCHEMBL12356618 0.75 ROCK2 (0.32) ROCK2ROCK1
SCHEMBL24456790 0.73
SCHEMBL21318183 0.73
SCHEMBL22009744 0.73
SCHEMBL2915463 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed